
Nicholas Verdini, MD
@nick_verdini
Transitional Year PGY-1 | Future RadOnc Resident at Stanford ☢️ | Tufts School of Medicine Alum
ID: 747753658931093504
28-06-2016 11:28:59
355 Tweet
292 Followers
542 Following

☢️🦴 In a multi-center RCT ⚖️ (n=78), radiation to high-risk asymptomatic bone metastases ⬇️ skeletal-related events and prolonged overall survival in metastatic solid tumors: brnw.ch/21wE43a #radonc Erin Gillespie, MD MPH




Awesome NEJM piece "What Is a Mentor?" Well worth the read. @cd_fuller Erin Gillespie, MD MPH Dan Golden MD MHPE Radiation Oncology | Dartmouth Cancer Center ARRO ACROresident Tag anyone else that is interested in #RadOnc #Mentorship🙂 nejm.org/doi/full/10.10…

New by PGY2 Dr Nikhil Mankuzhy, MD with Dr Suzanne Wolden: Re-irradiation with hypofractionation for locally recurrent diffuse intrinsic pontine glioma #DIPG achieved survival duration comparable to published outcomes & effectively palliated symptoms. #pedcsm onlinelibrary.wiley.com/doi/10.1002/pb…


🎉 Congratulations 🎉 to all of this year's SCORE students who matched at Stanford Medicine. We can't wait to welcome you back to campus!


Using ePROs to prompt direct patient trial invitations resulted in greater enrollment to a symptom-intervention trial than standard of care physician-based referral. ja.ma/4cU8lin Nicholas Verdini, MD Jun J. Mao Erin Gillespie, MD MPH Memorial Sloan Kettering Radiation Oncology


📢 All new Student Scan out now! Check out hot topics in #RadiationOncology, an interview with Jillian Gunther MD, PhD, opportunities for career development, and more! Check it out ➡️ bit.ly/4aAW68L @lauramaule3 Josh Qian Sylvia Choo Anthony Alanis #RadOncEd #MedEd



Using ePROs to prompt direct patient trial invitations resulted in greater enrollment to a symptom-intervention trial than standard of care physician-based referral. Nicholas Verdini, MD Jun J. Mao Erin Gillespie, MD MPH Memorial Sloan Kettering Radiation Oncology ja.ma/3KTTGXW

Very proud of this #ClinicalTrial of Cabozantinib/Nivolumab #CaboNivo & Cabozantinib/ Nivolumab/Ipilimumab #CaboNivoIpi published Journal of Clinical Oncology, that includes #rareGUtumors & took years to complete but laid the foundation for many future trials in oncology gcc02.safelinks.protection.outlook.com/?url=https%3A%…


☢️Celiac plexus radiation for pain management in pancreatic cancer The Lancet Oncology ✅At 3 weeks, 53% of the patients had at least a partial pain response ✅A non-invasive, relatively safe treatment 👉doi.org/10.1016/S1470-… The Lancet ESTRO ASTRO PanCAN M. Bolton



Congrats to Nicholas Verdini, MD on his receipt of the ARRO/ROI joint DEI Publication Award, recognizing a trainee who has published work on a topic related to DEI. Nick investigated PROs as a recruitment strategy for trial enrollment. 🏆🔥 Stanford Radiation Oncology Radiation Oncology Institute-The ASTRO Foundation ARRO


Congrats to Nicholas Verdini, MD on the ARRO Radiation Oncology Institute-The ASTRO Foundation DEI Publication Award 👏 #astro24


Thrilled to welcome our new Stanford Radiation Oncology Residents residents to our family!! 🎉 Huge congratulations to Kathryn Achuck, Nicholas Mullen, Amira Osman-Short, and Sarah Seiter! We’re THRILLED to have you all join the Stanford family! #RadOnc #Match2025 Stanford Medicine Stanford Radiation Oncology
